D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation - observations from the ARISTOTLE trial-Reference-Cited by-同舟云学术

D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation - observations from the ARISTOTLE trial

Published:2014-07-24 Issue:9 Volume:12 Page:1401-1412
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Christersson C.¹,Wallentin L.¹²,Andersson U.²,Alexander J. H.³,Ansell J.⁴,De Caterina R.⁵,Gersh B. J.⁶,Granger C. B.³,Hanna M.⁷,Horowitz J. D.⁸,Huber K.⁹,Husted S.¹⁰,Hylek E. M.¹¹,Lopes R. D.³,Siegbahn A.²¹²

Affiliation:

1. Department of Medical Sciences; Cardiology; Uppsala University; Uppsala Sweden

2. Uppsala Clinical Research Center (UCR); Uppsala University; Uppsala Sweden

3. Duke University; Medical Center; Durham NC USA

4. Lenox Hill Hospital; New York NY USA

5. Gabriele d'Annunzio University; Chieti, and Gabriele Monasterio Foundation; Pisa Italy

6. Mayo Clinic College of Medicine; Rochester MN USA

7. Bristol-Myers Squibb; Princeton NJ USA

8. University of Adelaide; Adelaide SA Australia

9. Department of Internal Medicine, Cardiology and Emergency Medicine; Wilhelminen Hospital; Vienna Austria

10. Medical Department; Hospital Unit West; Herning/Holstebro Denmark

11. Boston University Medical Center; Boston MA USA

12. Department of Medical Sciences; Clinical Chemistry; Uppsala University; Uppsala Sweden

Funder

AstraZeneca, and Boehringer-Ingelheim

UCR

Bristol-Myers Squibb

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12638/fullpdf

Reference35 articles.

1. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study;Benjamin;Circulation,1998

2. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates;Kannel;Am J Cardiol,1998

3. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation;Hart;Ann Intern Med,2007

4. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

5. Apixaban versus warfarin in patients with atrial fibrillation;Granger;N Engl J Med,2011

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. D-dimer and fibrinogen indicate ischemic risk in patients with atrial fibrillation after percutaneous coronary intervention;Thrombosis Journal;2024-05-21

2. Omega-3 Fatty Acids and Markers of Thrombosis in Patients with Atrial Fibrillation;Nutrients;2024-01-05

3. Role of the score for the targeting of atrial fibrillation (STAF) combined with D-dimer in screening ischemic stroke patients with atrial fibrillation;Journal of Medical Biochemistry;2024

4. Mechanisms and Prediction of Ischemic Stroke in Atrial Fibrillation Patients;Journal of Clinical Medicine;2023-10-12

5. Coagulation Biomarkers and Clinical Outcomes in Elderly Patients With Nonvalvular Atrial Fibrillation;JACC: Asia;2023-08